Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

5.68
Delayed Data
As of Dec 02
 -0.31 / -5.18%
Today’s Change
5.67
Today|||52-Week Range
20.22
-65.66%
Year-to-Date

Today’s Trading

Previous close5.99
Today’s open6.01
Day’s range5.67 - 6.10
Volume651,060
Average volume (3 months)248,073
Market cap$142.8M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-25.40%
Earnings growth (this year)+12.13%
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+68.18%
P/E ratio--
Price/Sales34.95
Price/Book1.06

Competitors

 Today’s
change
Today’s
% change
IMGNImmunoGen Inc+0.11+6.21%
ENZYEnzymotec Ltd-0.05-0.79%
NVIVInVivo Therapeutics ...-0.15-3.03%
VBLTVascular Biogenics L...+0.05+0.96%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateApril 10, 2017
EPS forecast (this quarter)-$0.65
Annual revenue (last year)$10.5M
Annual profit (last year)-$79.3M
Net profit margin-758.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, CFO &
Executive Director
Matt Kapusta
Chief Operating Officer
Eric Goossens
Corporate headquarters
Amsterdam, Noord-holland

Forecasts


Search for Jobs